Dapagliflozin in patients with heart failure and reduced ejection fraction JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ... New England Journal of Medicine 381 (21), 1995-2008, 2019 | 6235 | 2019 |
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute … Authors/Task Force Members, CW Hamm, JP Bassand, S Agewall, J Bax, ... European heart journal 32 (23), 2999-3054, 2011 | 5108 | 2011 |
Coronary-artery bypass surgery in patients with left ventricular dysfunction EJ Velazquez, KL Lee, MA Deja, A Jain, G Sopko, A Marchenko, IS Ali, ... New England Journal of Medicine 364 (17), 1607-1616, 2011 | 1452 | 2011 |
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials SL Kristensen, R Rørth, PS Jhund, KF Docherty, N Sattar, D Preiss, ... The lancet Diabetes & endocrinology 7 (10), 776-785, 2019 | 1369 | 2019 |
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the … K Sliwa, D Hilfiker-Kleiner, MC Petrie, A Mebazaa, B Pieske, E Buchmann, ... European journal of heart failure 12 (8), 767-778, 2010 | 1300 | 2010 |
Coronary-artery bypass surgery in patients with ischemic cardiomyopathy EJ Velazquez, KL Lee, RH Jones, HR Al-Khalidi, JA Hill, JA Panza, ... New England Journal of Medicine 374 (16), 1511-1520, 2016 | 1016 | 2016 |
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology NM Hawkins, MC Petrie, PS Jhund, GW Chalmers, FG Dunn, ... European journal of heart failure 11 (2), 130-139, 2009 | 791 | 2009 |
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in … MR MacDonald, MC Petrie, F Varyani, J Östergren, EL Michelson, ... European heart journal 29 (11), 1377-1385, 2008 | 784 | 2008 |
Randomised controlled trial of specialist nurse intervention in heart failure L Blue, E Lang, JJV McMurray, AP Davie, TA McDonagh, DR Murdoch, ... Bmj 323 (7315), 715-718, 2001 | 712 | 2001 |
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology PM Seferović, MC Petrie, GS Filippatos, SD Anker, G Rosano, ... European journal of heart failure 20 (5), 853-872, 2018 | 697 | 2018 |
Clinical epidemiology of heart failure: public and private health burden. JJ McMurray, MC Petrie, DR Murdoch, AP Davie European heart journal 19, P9-16, 1998 | 617 | 1998 |
Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand, J Bělohlávek, ... Jama 323 (14), 1353-1368, 2020 | 497 | 2020 |
Declining risk of sudden death in heart failure L Shen, PS Jhund, MC Petrie, BL Claggett, S Barlera, JGF Cleland, ... New England Journal of Medicine 377 (1), 41-51, 2017 | 497 | 2017 |
Do patients with suspected heart failure and preserved left ventricular systolic function suffer from “diastolic heart failure” or from misdiagnosis? A prospective descriptive … L Caruana, MC Petrie, AP Davie, JJV McMurray Bmj 321 (7255), 215-218, 2000 | 468 | 2000 |
Semaglutide in patients with heart failure with preserved ejection fraction and obesity MN Kosiborod, SZ Abildstrøm, BA Borlaug, J Butler, S Rasmussen, ... New England Journal of Medicine 389 (12), 1069-1084, 2023 | 438 | 2023 |
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study … J Bauersachs, T König, P van der Meer, MC Petrie, D Hilfiker‐Kleiner, ... European journal of heart failure 21 (7), 827-843, 2019 | 383 | 2019 |
Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial MR MacDonald, DT Connelly, NM Hawkins, T Steedman, J Payne, ... Heart 97 (9), 740-747, 2011 | 366 | 2011 |
Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial MN Kosiborod, PS Jhund, KF Docherty, M Diez, MC Petrie, S Verma, ... Circulation 141 (2), 90-99, 2020 | 365 | 2020 |
A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left … JJV McMurray, DL DeMets, SE Inzucchi, L Køber, MN Kosiborod, ... European journal of heart failure 21 (5), 665-675, 2019 | 354 | 2019 |
Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) MMY Lee, KJM Brooksbank, K Wetherall, K Mangion, G Roditi, ... Circulation 143 (6), 516-525, 2021 | 349 | 2021 |